Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients. The company offers contract research development and manufacturing services, such as end-to-end services across the new chemical entity and new biological entity lifecycles, as well as engages in contract research, development, and manufacturing of development batches of molecules used for clinical trials up to commercial manufacturing for small molecules and biologics. It also manufactures and sells specialized fermentation-based active pharmaceutical ingredients, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. The company was incorporated in 2006 and is based in Bengaluru, India.
Low
579.15
High
977.55
Low
830.60
High
859.75
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How ANTHEM BIOSCIENCES LTD stacks up against its Biotechnology peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ANTHEM ANTHEM BIOSCIENCES LTD | 858.50 | 0.01% | 84.37 | 10.18 | 48,195 | 3.43% | 3.93% | 977.55 / 579.15 |
| 2 | BIOCON Biocon Limited | 371.40 | 0.30% | 109.95 | 3.38 | 60,381 | 9.61% | 6.42% | 447.15 / 337.70 |
| 3 | BLUEJET Blue Jet Healthcare Limited | 542.00 | 0.73% | 40.01 | 13.55 | 10,259 | 8.14% | 18.85% | 692.90 / 325.00 |
| 4 | CONCORDBIO Concord Biotech Limited | 1,399.00 | 1.85% | 53.18 | 26.31 | 14,636 | 10.15% | 16.48% | 1,667.60 / 987.00 |
| 5 | DCAL Dishman Carbogen Amcis Limited | 149.60 | 5.00% | 145.83 | 1.03 | 2,357 | 14.39% | 43.27% | 306.00 / 128.50 |
| 6 | ONESOURCE ONESOURCE SPECL PHARMA L | 1,500.00 | 1.42% | 0.00 | -4.25 | 17,201 | 2.02% | 20.68% | 1,925.00 / 1,057.00 |
| 7 | PANACEABIO Panacea Biotec Limited | 358.50 | 2.05% | 0.00 | -1.16 | 2,196 | 11.81% | 13.95% | 647.00 / 292.40 |
| 8 | SUPRIYA Supriya Lifescience Limited | 925.00 | 2.66% | 0.00 | 0.00 | 7,489 | 16.04% | 41.23% | 1,085.00 / 545.50 |
| 9 | ZOTA Zota Health Care Limited | 1,253.10 | 3.21% | 0.00 | -30.88 | 4,340 | 15.29% | 3.66% | 1,740.00 / 1,022.00 |